209 related articles for article (PubMed ID: 30466156)
21. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
[TBL] [Abstract][Full Text] [Related]
22. Bone interface modulates drug resistance in breast cancer bone metastasis.
Kar S; Katti DR; Katti KS
Colloids Surf B Biointerfaces; 2020 Nov; 195():111224. PubMed ID: 32634713
[TBL] [Abstract][Full Text] [Related]
23. Immune system augmentation via humanization using stem/progenitor cells and bioengineering in a breast cancer model study.
Shafiee A; McGovern JA; Lahr CA; Meinert C; Moi D; Wagner F; Landgraf M; De-Juan-Pardo E; Mazzieri R; Hutmacher DW
Int J Cancer; 2018 Sep; 143(6):1470-1482. PubMed ID: 29659011
[TBL] [Abstract][Full Text] [Related]
24. Enhanced Metastatic Potential in a 3D Tissue Scaffold toward a Comprehensive in Vitro Model for Breast Cancer Metastasis.
Balachander GM; Balaji SA; Rangarajan A; Chatterjee K
ACS Appl Mater Interfaces; 2015 Dec; 7(50):27810-22. PubMed ID: 26599258
[TBL] [Abstract][Full Text] [Related]
25. Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model.
Moreau JE; Anderson K; Mauney JR; Nguyen T; Kaplan DL; Rosenblatt M
Cancer Res; 2007 Nov; 67(21):10304-8. PubMed ID: 17974972
[TBL] [Abstract][Full Text] [Related]
26. Tissue-engineered 3D models for elucidating primary and metastatic bone cancer progression.
González Díaz EC; Sinha S; Avedian RS; Yang F
Acta Biomater; 2019 Nov; 99():18-32. PubMed ID: 31419564
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts.
Haupt LM; Thompson EW; Trezise AE; Irving RE; Irving MG; Griffiths LR
BMC Cancer; 2006 Jan; 6():18. PubMed ID: 16430785
[TBL] [Abstract][Full Text] [Related]
28. Microenvironmental stimuli affect Endothelin-1 signaling responsible for invasiveness and osteomimicry of bone metastasis from breast cancer.
Bendinelli P; Maroni P; Matteucci E; Luzzati A; Perrucchini G; Desiderio MA
Biochim Biophys Acta; 2014 Apr; 1843(4):815-26. PubMed ID: 24373848
[TBL] [Abstract][Full Text] [Related]
29. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
Kasper G; Reule M; Tschirschmann M; Dankert N; Stout-Weider K; Lauster R; Schrock E; Mennerich D; Duda GN; Lehmann KE
BMC Cancer; 2007 Jan; 7():12. PubMed ID: 17233884
[TBL] [Abstract][Full Text] [Related]
30. In vitro microenvironments to study breast cancer bone colonisation.
Taubenberger AV
Adv Drug Deliv Rev; 2014 Dec; 79-80():135-44. PubMed ID: 25453260
[TBL] [Abstract][Full Text] [Related]
31. Osteomimetic matrix components alter cell migration and drug response in a 3D tumour-engineered osteosarcoma model.
Pavlou M; Shah M; Gikas P; Briggs T; Roberts SJ; Cheema U
Acta Biomater; 2019 Sep; 96():247-257. PubMed ID: 31302294
[TBL] [Abstract][Full Text] [Related]
32. Expression of interleukin 8 and not parathyroid hormone-related protein by human breast cancer cells correlates with bone metastasis in vivo.
Bendre MS; Gaddy-Kurten D; Mon-Foote T; Akel NS; Skinner RA; Nicholas RW; Suva LJ
Cancer Res; 2002 Oct; 62(19):5571-9. PubMed ID: 12359770
[TBL] [Abstract][Full Text] [Related]
33. Engineering a Novel 3D Printed Vascularized Tissue Model for Investigating Breast Cancer Metastasis to Bone.
Cui H; Esworthy T; Zhou X; Hann SY; Glazer RI; Li R; Zhang LG
Adv Healthc Mater; 2020 Aug; 9(15):e1900924. PubMed ID: 31846231
[TBL] [Abstract][Full Text] [Related]
34. Involvement of cell-cell and cell-matrix interactions in bone destruction induced by metastatic MDA-MB-231 human breast cancer cells in nude mice.
Nakamura H; Hiraga T; Ninomiya T; Hosoya A; Fujisaki N; Yoneda T; Ozawa H
J Bone Miner Metab; 2008; 26(6):642-7. PubMed ID: 18979165
[TBL] [Abstract][Full Text] [Related]
35. P2Y2 nucleotide receptor-mediated extracellular signal-regulated kinases and protein kinase C activation induces the invasion of highly metastatic breast cancer cells.
Eun SY; Ko YS; Park SW; Chang KC; Kim HJ
Oncol Rep; 2015 Jul; 34(1):195-202. PubMed ID: 26063340
[TBL] [Abstract][Full Text] [Related]
36. Umbilical cord-derived mesenchymal stem cells promote proliferation and migration in MCF-7 and MDA-MB-231 breast cancer cells through activation of the ERK pathway.
Li T; Zhang C; Ding Y; Zhai W; Liu K; Bu F; Tu T; Sun L; Zhu W; Zhou F; Qi W; Hu J; Chen H; Sun X
Oncol Rep; 2015 Sep; 34(3):1469-77. PubMed ID: 26151310
[TBL] [Abstract][Full Text] [Related]
37. Alteration in composition of keratin intermediate filaments in a model of breast cancer progression and the potential to reverse hallmarks of metastasis.
Mackinder MA; Evans CA; Chowdry J; Staton CA; Corfe BM
Cancer Biomark; 2012; 12(2):49-64. PubMed ID: 23396250
[TBL] [Abstract][Full Text] [Related]
38. NOTCH3 expression is linked to breast cancer seeding and distant metastasis.
Leontovich AA; Jalalirad M; Salisbury JL; Mills L; Haddox C; Schroeder M; Tuma A; Guicciardi ME; Zammataro L; Gambino MW; Amato A; Di Leonardo A; McCubrey J; Lange CA; Liu M; Haddad T; Goetz M; Boughey J; Sarkaria J; Wang L; Ingle JN; Galanis E; D'Assoro AB
Breast Cancer Res; 2018 Sep; 20(1):105. PubMed ID: 30180881
[TBL] [Abstract][Full Text] [Related]
39. Modeling the breast cancer bone metastatic niche in complex three-dimensional cocultures.
Marlow R; Dontu G
Methods Mol Biol; 2015; 1293():213-20. PubMed ID: 26040690
[TBL] [Abstract][Full Text] [Related]
40. 3D extracellular matrix interactions modulate tumour cell growth, invasion and angiogenesis in engineered tumour microenvironments.
Taubenberger AV; Bray LJ; Haller B; Shaposhnykov A; Binner M; Freudenberg U; Guck J; Werner C
Acta Biomater; 2016 May; 36():73-85. PubMed ID: 26971667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
